/R E P E A T -- Sirona Biochem Announces Discovery of Anti-Cellulite Activity in Compounds/ Biotech Investing
SHAREHOLDER ALERT: WeissLaw LLP Reminds DSPG, ADTN, TRIL, and VNE Shareholders About Its Ongoing Investigations Biotech Investing
AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa for the Treatment of Patients 16 Years and Older with Moderate to Severe Crohn's Disease Biotech Investing
Gilead to Present Latest Antiviral Research Data Addressing Urgent Global Needs in Infectious Disease at IDWeek 2021 Biotech Investing
U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for LAG-3-Blocking Antibody Relatlimab and Nivolumab Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo + Chemotherapy for Patients with HER2-Negative Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma whose Tumors Express PD-L1 with CPS ? 5 Biotech Investing
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, DSPG, LMRK, TRIL; Shareholders are Encouraged to Contact the Firm Biotech Investing
